R. Rao Koganty
2006
In 2006, R. Rao Koganty earned a total compensation of $164.8K as Vice President and General Manager Synthetic Biologics Business Unit at Oncothyreon.
Compensation breakdown
| Non-Equity Incentive Plan | $29,801 |
|---|---|
| Salary | $129,595 |
| Other | $5,382 |
| Total | $164,778 |
Koganty received $129.6K in salary, accounting for 79% of the total pay in 2006.
Koganty also received $29.8K in non-equity incentive plan and $5.4K in other compensation.
Rankings
In 2006, R. Rao Koganty's compensation ranked 6,634th out of 7,022 executives tracked by ExecPay. In other words, Koganty earned more than 5.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,634 out of 7,022 | 6th |
Division Services | 872 out of 916 | 5th |
Major group Engineering, Accounting, Research, Management, And Related Services | 94 out of 97 | 3rd |
Industry group Research, Development, And Testing Services | 42 out of 43 | 2nd |
Industry Commercial Physical and Biological Research | 42 out of 43 | 2nd |
Source: SEC filing on April 29, 2008.
Koganty's colleagues
We found five more compensation records of executives who worked with R. Rao Koganty at Oncothyreon in 2006.
2006
Edward Taylor
Oncothyreon
Chief Financial Officer
2006
Robert Kirkman
Oncothyreon
Chief Executive Officer
2006
Robert Aubrey
Oncothyreon
Former Vice President, Business Development
2006
Marilyn Olson
Oncothyreon
Vice President, Clinical Regulatory Affairs
2006
D Kirkpatrick
Oncothyreon